Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial-Reference-Cited by-同舟云学术

Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial

Published:2021-02-07 Issue:4 Volume:28 Page:432-438
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Minagawa Tomonori¹,Oguchi Tomohiko²,Saitou Tetsuichi¹,Fukazawa Ayumu³,Hashida Iwao⁴,Koiwai Keiichiro³,Iijima Kazuyoshi²,Kato Haruaki²,Ogawa Teruyuki¹,Ishizuka Osamu¹

Affiliation:

1. Department of Urology Shinshu University Matsumoto City NaganoJapan

2. Department of Urology Nagano Municipal Hospital Nagano City NaganoJapan

3. Department of Radiology Shinshu University Matsumoto City NaganoJapan

4. Department of Radiology Nagano Municipal Hospital Nagano City Nagano Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14487

Reference30 articles.

1. Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival Following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience

2. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer

3. Patient and Treatment Factors Associated With Complications After Prostate Brachytherapy

4. Complications Following Permanent Prostate Brachytherapy

5. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 63 ADVERSE EFFECTS ON LOWER URINARY TRACT SYMPTOMS AND DYSFUNCTIONS AFTER CARBON-ION RADIOTHERAPY FOR PROSTATE CANCER PATIENTS;Continence;2022-06

2. Editorial Comment to Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil;International Journal of Urology;2021-09-08

3. Factors affecting urinary frequency after low‐dose‐rate brachytherapy for prostate cancer;LUTS: Lower Urinary Tract Symptoms;2021-07-20

4. Editorial Comment to Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial;International Journal of Urology;2021-02-07